CYANOTECH CORP (CYAN)

Kritische 8-K Meldungen

DatumMeldungSchwereFilingAuszug
22.08.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECthe Exchange Act. ☐         Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
08.05.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECorporated herein by reference.   Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme
23.08.2024Item 5.02 — Abgang SchlüsselpersonenHOCHSEC☐           Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Stammdaten

Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.

Unternehmen & Branche

NameCYANOTECH CORP
TickerCYAN
CIK0000768408
BoerseUS
SektorConsumer Defensive
IndustriePackaged Foods
SIC2833 · Medicinal Chemicals & Botanical Products

Wertpapier & Kennzahlen

CUSIP232437301
ISINUS2324373016
TypCommon Stock
Marktkapitalisierung2,9 Mio. USD
Beta-0,08
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-09-3010-Q6,976,0001,0000.0024,027,0008,065,000
2025-06-3010-Q5,820,000-926,00022,995,0008,000,000
2025-03-3110-K24,215,000-3,203,00023,490,0008,884,000
2024-12-3110-Q6,172,000-224,00023,956,0009,500,000
2024-09-3010-Q5,845,000-1,150,000-0.1623,913,0009,692,000
2024-06-3010-Q5,898,000-1,202,000-0.1724,432,00010,660,000
2024-03-3110-K23,071,000-5,267,000-0.8125,112,00011,814,000
2023-12-3110-Q5,582,000-1,020,000-0.1627,254,00013,833,000
2023-09-3010-Q6,373,000-797,000-0.1328,082,00014,407,000
2023-06-3010-Q5,146,000-1,369,000-0.2229,132,00015,040,000
2023-03-3110-K23,178,000-3,440,000-0.5529,728,00016,347,000
2022-12-3110-Q5,891,000-598,000-0.1029,772,00017,733,000
2022-09-3010-Q5,179,000-940,000-0.1530,353,00018,286,000
2022-06-3010-Q6,716,000-472,000-0.0830,716,00019,034,000
2022-03-3110-K35,968,0002,154,0000.3532,045,00019,487,000
2021-12-3110-Q9,459,000386,0000.0631,301,00019,197,000
2021-09-3010-Q9,419,000970,0000.1630,877,00018,613,000
2021-06-3010-Q8,964,000520,0000.0831,167,00017,580,000
2021-03-3110-K32,345,000-200,0000.1530,879,00017,041,000
2020-12-3110-Q6,985,000827,0000.1331,113,00017,157,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2023. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
VANGUARD GROUP INC52,82247,00638.63
TRAPHAGEN INVESTMENT ADVISORS LLC30,60027,23122.38
GEODE CAPITAL MANAGEMENT, LLC27,27024,00019.72
SUSQUEHANNA INTERNATIONAL GROUP, LLP12,78911,2569.25
BlackRock Finance, Inc.10,7629,5777.87
Tower Research Capital LLC (TRC)2,2341,9881.63
MORGAN STANLEY3182830.23
Farther Finance Advisors, LLC2001760.14
RENAISSANCE TECHNOLOGIES LLC147,4091310.11
WELLS FARGO & COMPANY/MN40360.03

Hinweis

Erweitert ×